Tadea in 2025: the debt is gone, but the value cushion is gone too

Getting To Know The Company

Tadea in 2025 is not an operating-company story. It is the story of a small holding company that is left with very little cushion. A reader who looks only at the headline, "the bank debt was repaid," could easily conclude that the company completed a successful balance-sheet cleanup. That is only partly true. What actually happened is that Nitzavim, the only holding that had already turned into real cash, was sold, and most of that cash then went into extinguishing debt, paying taxes, and funding the parent company's ongoing cash burn.

What is working now is clear enough. The sale of the remaining Nitzavim stake in June 2025 allowed Tadea to repay about NIS 7 million of bank credit, and by the reporting date it had no loans or utilized credit lines. The company also ended the year with NIS 2.708 million of cash, up from NIS 880 thousand at the end of 2024. On a quick screen, that looks like a move from a stressed company to a lighter one.

But that is exactly where the surface read becomes misleading. At the end of 2025 Tadea also had NIS 3.720 million of current taxes payable, NIS 478 thousand owed to suppliers, and NIS 588 thousand of accrued expenses and other payables. In other words, even after the bank debt was eliminated, the layer of current liabilities was still larger than the cash balance. The company finished the year with negative working capital of NIS 1.842 million, an equity deficit of NIS 322 thousand, and a going-concern note. The debt fell, but the problem did not disappear. It only changed shape.

What else can a reader miss at first glance? The erosion in the value layer. Illiquid financial assets measured at fair value through profit or loss fell from NIS 12.393 million to NIS 1.203 million in a single year, and investments accounted for under the equity method fell from NIS 5.759 million to zero. So in the same year that Tadea became less leveraged, it also became poorer in balance-sheet value that is actually recognized.

That is also the real bottleneck for 2026. It is no longer bank financing. It is a race between value realization and cash burn. For the read to improve, at least one of three things has to happen: another asset realization, a material improvement in one of the portfolio companies that can create value that is actually monetizable, or a fresh debt or equity raise that pushes the liquidity question out again. Until then, even real optionality remains mostly an idea.

Tadea itself has framed that strategic direction since late 2022: focus on improving existing investments and realizing them, not on finding new ones. That wording matters. It means the company is no longer presenting itself as an open-ended investment platform. It is presenting itself as a vehicle that has to extract value from what it already owns. That is a meaningful difference.

The Economic Map At Year-End 2025

That chart is the core of the Tadea read. The balance sheet is indeed less leveraged, but it is also much thinner. Anyone who sees only the decline in debt and not the disappearance of the value cushion is missing what actually happened.

Events And Triggers

The first trigger: the Nitzavim sale is the only event in 2025 that turned theoretical value into tangible cash. Tadea's share of the sale proceeds was NIS 7.712 million, and Nitzavim also repaid shareholder loans to Tadea totaling NIS 5.875 million. After the payment to Nitzavim's former CEO, Tadea presents total cash flow of NIS 11.543 million from the completion of the sale. In the cash-flow statement as a whole, investing activity generated NIS 13.074 million net.

The second trigger: that same sale enabled the company to eliminate its bank debt. In June 2025 Tadea repaid the remaining bank credit, about NIS 7 million, and by the reporting date it had no utilized bank facilities. That is positive, but it needs to be framed correctly: it did not come from stronger ongoing parent-company economics. It came from monetizing the one asset that was already ready for sale.

The third trigger: lower leverage came with deep portfolio markdowns. The carrying value of the Questar stake fell to NIS 834 thousand from NIS 3.878 million just six months earlier. The carrying value of the Centerity stake fell to NIS 247 thousand from NIS 598 thousand in June 2025. In both cases the company states explicitly that the decline reflects failure to meet the 2025 budget and lower forward forecasts.

The fourth trigger: the 2025 statements also contain one positive signal, but it still sits at the level of an option. BeyondEdge, held through Molodan at 22.23%, continues to work with Corning, which committed to minimum annual software-license purchases of $3 million in each of 2023, 2024, and 2025, and the parties extended the arrangement on the same terms into 2026. In addition, in the first quarter of 2026 Corning purchased another license for BeyondEdge's operating system. That is an important commercial thread, but it is still not backed by balance-sheet value at Tadea.

The fifth trigger: the immediate governance context around the report does not materially change the thesis. Yitzhak Zauberman ceased serving as an independent director on December 28, 2025, and Raz Dehan was appointed a regular director effective March 22, 2026. That is a governance update, not an event that changes the economics of the company.

That chart sharpens what the headline "cash increased" blurs. The increase in cash did not come from operations. It came from selling Nitzavim, and then part of it was consumed by negative operating cash flow and debt repayment.

Efficiency, Profitability, And Competition

The main insight in this section is that Tadea should not be judged through the operating margin of a parent company. It should be judged through the quality of the value inside the portfolio companies and the ability of that value to move upward. The 2025 statements contain two very different pictures: Questar shows mix improvement, Centerity shows unusually strong gross efficiency, but both remain far from creating clean and simple value for the parent.

Questar: the mix improved, but the road to cash is still long

Questar ended 2025 with revenue of $14.0 million, down 19% from $17.323 million in 2024, after revenue had already fallen 36% in 2024 from 2023. On the other hand, gross margin improved to 41% from 37% in 2024 and just 27% in 2023, mainly because the company is selling more software and less hardware.

This is where it is easy to make the wrong call. A reader who focuses only on the gross-margin improvement could conclude that Questar has already turned the corner. That is the mistake. Under the mix improvement there is still a very heavy cost base. Research and development expense was $10.384 million in 2025, or 74% of revenue, and operating loss remained negative at $10.302 million. Net loss was still $15.321 million.

In other words, Questar still looks more like a product platform that has not yet reached the scale it needs than like a business that has already proven a stable economic engine. The valuation assumes that revenue will rise to $19.888 million in 2026 thanks to a new software product and stronger sales in the Americas, but even in the valuation case itself the company is still showing a 2026 operating loss of $796 thousand and negative free cash flow of $348 thousand.

That is before an even more important layer. The valuation states explicitly that the company needs funding in the short term and that there is no shareholder commitment to provide it. The value is built on the assumption that shareholders will act rationally and preserve going-concern value because that is better than liquidation value. That is polite wording, but the meaning is simple: even at Questar, the valuation is still contingent.

Centerity: exceptional gross margin, but the capital stack wipes out almost everything

Centerity presents a different picture: a small business with very high gross margin, but with a capital structure that is almost impassable for ordinary shareholders. In the first three quarters of 2025, revenue was just $1.791 million and gross profit was $1.666 million, or 93% of revenue. That is an unusual number.

But here too the comfortable conclusion would be wrong. In the same period, research and development expense was $2.241 million and selling, general, and administrative expense was $2.359 million. As a result, operating loss was $2.934 million and net loss was $3.159 million. On September 30, 2025, Centerity had just $61 thousand of cash, $5.097 million of current liabilities, $10.923 million of long-term shareholder loans, and negative equity of $15.203 million.

That is the point the valuation translates brutally. The economic value of Centerity as a whole at December 31, 2025 was estimated at only $1.691 million. Against that sits a preferred liquidation stack of $59.025 million ahead of common equity. So what is left for Tadea is not value derived from its nominal ownership percentage. It is only about $77.4 thousand through CLA rights. This is almost a textbook example of the gap between an ownership percentage on paper and the value that is actually left for the parent after the preference layers.

What this means at the parent level

What matters is not whether Questar or Centerity can look better a year from now. It is how any improvement actually translates to Tadea. At Questar, the challenge is funding and reaching a growth rate that can justify enterprise value. At Centerity, the challenge is deeper: even if the business improves operationally, the preferred stack already absorbs almost all of the current value.

That is also why Tadea's balance sheet now looks like the balance sheet of a waiting vehicle, not a comfortable holding company. There is no single large asset that is clearly approaching monetization. There are several engines that still need another layer of funding, execution, or capital-structure unwinding.

Cash Flow, Debt, And Capital Structure

The right cash-flow frame for Tadea is all-in cash flexibility, not a normalized cash-generation view. The reason is simple: the thesis here is not about the cash-generating power of a mature operating business. It is about how much cash is left at the parent after all of its real uses of cash.

On that basis, 2025 looks like this: negative operating cash flow of NIS 4.869 million, positive investing cash flow of NIS 13.074 million, negative financing cash flow of NIS 6.392 million, and a net increase in cash of NIS 1.828 million. There is no room for confusion here. The cash flexibility of 2025 came from Nitzavim, not from recurring operations.

The income statement shows the same gap from a different angle. Net loss narrowed to NIS 1.920 million from NIS 16.215 million in 2024, but that does not mean Tadea became profitable. Other net finance expense fell to just NIS 436 thousand after reaching NIS 16.358 million in 2024. The main reason is that the layer of negative revaluation effects in 2025 was much smaller than in 2024. That helps the bottom line, but it does not replace actual realization of value.

At the same time, the current balance sheet remained tight. At the end of 2025 there were, as noted, NIS 2.708 million of cash against NIS 3.720 million of current taxes payable, NIS 478 thousand owed to suppliers, and NIS 588 thousand of accrued expenses and other payables. So the fact that there is no utilized bank debt is clearly positive, but it is still not the same thing as having a free cash cushion.

The semi-liquid layer of the balance sheet is also now very small. The company recognizes Questar at NIS 957 thousand. It recognizes a Centerity debt instrument at NIS 246 thousand. BeyondEdge and Oceansix are not currently providing balance-sheet support. So anyone looking for flexibility has to focus not only on the absence of debt, but also on the fact that the assets that can support the parent today are very small.

That chart clarifies why the going-concern note remained even after the debt cleanup. The cash layer and the recognized-asset layer are simply not thick enough relative to current liabilities.

Guidance And Forward View

Before getting into the detail, these are the five non-obvious points that explain 2026:

First finding: 2025 did not solve the holding-company model. It only replaced bank debt with lower portfolio value and a sharper liquidity question.

Second finding: Nitzavim was both the source of cash flow and the source of balance-sheet quality. After the sale, Tadea does not have another asset that has already translated into cash with similar certainty.

Third finding: the decline in Questar and Centerity valuations was not just a market-assumption reset. It was explicitly tied to missing the 2025 budget and cutting forward forecasts.

Fourth finding: at Centerity, almost the entire current value layer is absorbed before common equity. That means even business improvement may not quickly flow down to shareholders such as Tadea.

Fifth finding: BeyondEdge is the only positive thread left with a clear strategic customer and an extension into 2026, but it still does not provide Tadea with a balance-sheet anchor.

Questar needs to move from a growth presentation to growth financing

Questar's valuation presents 2026 revenue of $19.888 million, up 42% from 2025, with a new software product expected to support the mix. That is the constructive part.

The less comfortable part is that the valuation itself already discounts management's longer-term assumptions. While the company assumed annual growth of 40% between 2027 and 2030, the valuer cut that to 18%. The work also shows that equity value collapsed from $28.3 million in June 2025 to $7.6 million in December 2025, and that the cash on hand will last only a few months.

That leads to the right 2026 framing: this is not a breakout year. It is a funding and commercial proof year. The company needs to show that the new product can actually generate orders and that the next financing round can be completed without wiping out yet another layer of existing shareholders.

Centerity first has to survive its own capital structure

Centerity's forward case is not simple either. The valuation assumes revenue of $2.933 million in 2026, $5.279 million in 2027, and $13.861 million in the representative year, but EBITDA remains negative in 2026, 2027, and 2028, and turns positive only in 2029.

In other words, even if the strategy of working through partners, integrators, and OEM channels succeeds, the path to a point where common shareholders create meaningful value is still very long. That is why Centerity's equity value also fell from $2.8 million in June 2025 to $1.7 million in December 2025.

BeyondEdge is the option, not the base

If there is one component that could surprise on the upside over the medium term, it is BeyondEdge. The company already benefits from a multi-year arrangement with Corning, with minimum purchases of $3 million in each year from 2023 through 2026, and another license agreement was signed in the first quarter of 2026. That is meaningful.

But here too it is important to separate value created inside the investee from value that is accessible to Tadea. In Tadea's statements there is currently no accounting value layer to lean on in BeyondEdge. So the right way to read BeyondEdge is as a rise in optionality, not as a solution to the parent's liquidity position.

What kind of year comes next

For Tadea, 2026 looks like an expensive bridge year. It is not a collapse year, because there is no crushing bank debt right now. And it is not a breakout year, because there is still no fresh realization or operating proof that can replace Nitzavim. The coming year will be judged by whether one of the holdings starts to produce value that can actually move upward, or at least by whether the parent can get through the year without eroding the balance sheet further.

Risks

The first and clearest risk is parent-level liquidity risk. Management itself states that without realizing investments or raising debt or equity, there is uncertainty about the company's ability to meet obligations for a period exceeding 12 months. This is not a technical warning line. It is the correct reading frame for the entire report.

The second risk is minority-position risk. Tadea holds minority stakes in the portfolio companies, and the report states explicitly that it cannot direct their activity or necessarily sell its holdings at a timing and on terms that suit it. That matters especially when the whole model depends on value realization.

The third risk is valuation risk. The auditors flagged Questar and Centerity valuations this year as a key audit matter. That is an important external signal because it reminds readers that Tadea's balance sheet now depends on a high degree of judgment in valuing illiquid assets, while those assets have already shown very sharp volatility from year to year and even from half-year to half-year.

The fourth risk is funding risk inside the portfolio companies. Both Questar and Centerity are valued under going-concern assumptions that require future financing solutions. In Questar's case, the valuation states explicitly that there is no shareholder commitment to continue funding. In Centerity's case, there is a high probability that the convertible loans will turn into equity, which by itself signals that the debt does not look repayable in cash.

The fifth risk is the gap between nominal value and accessible value. That is especially visible at Centerity, but it is true at the group level as well: the fact that the company has ownership percentages, strategic partners, or interesting technology inside its investees still does not mean Tadea's shareholders have value they can actually capture.

Conclusions

Tadea ended 2025 in a position that looks cleaner, but in practice it is also more fragile. Selling Nitzavim solved the bank-debt problem and brought in cash, but at the same time it removed the only asset in the group that had already proven it could turn theoretical value into cash. What remains is a portfolio of options, some more interesting than others, and a parent company that is still burning cash and relying on future realization.

Current thesis in one line: Tadea should no longer be judged by whether it still owns interesting assets, but by whether one of them can turn into accessible cash at the parent in time.

What changed: debt fell to zero, but the value cushion eroded as well. Questar and Centerity were marked down, equity-method investments fell to zero, and the going-concern note stayed in place.

Counter-thesis: one could argue that the current balance sheet already reflects an overly severe outcome, and that a single additional realization, or even one proof point of commercialization at BeyondEdge or Questar, could create a very sharp change in how the stock is read.

What could change the market's interpretation in the short to medium term: another realization event, a clean funding round at Questar, a commercial signing that lifts BeyondEdge's value in a measurable way, or on the other side another write-down and continued erosion in cash.

Why this matters: in Tadea of 2025, the gap between value and accessible value is not a side analytical note. It is the whole story.

What has to happen over the next 2 to 4 quarters: either the company realizes another asset, or one of the holdings creates a step-up that can actually translate into funding and value at the parent, or Tadea will have to look for outside capital again. What would undermine the thesis is continued negative operating cash flow with no realization event and no measurable commercial improvement.